Articles citing this paper
Under-utilisation of cardioprotective glucose-lowering medication in diabetics living with HIV
Bakani Butale
A * , Ian Woolley A B , Kathryn Cisera B , Tony Korman A B and Georgia Soldatos C
+ Author Affiliations
- Author Affiliations
A Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Vic., Australia.
B Monash Infectious Diseases, Monash Health, Melbourne, Vic., Australia.
C Monash Diabetes and Vascular Medicine Unit, Monash Health, Melbourne, Vic., Australia.
Sexual Health 19(6) 580-582 https://doi.org/10.1071/SH22070
Submitted: 19 April 2022 Accepted: 29 July 2022 Published: 23 August 2022
2 articles found in Crossref database.
GLP‐1 agonists for people living with HIV and obesity, is there a potential?
Zino L.,
Tack C. J.,
Richel O., Burger D. M.
HIV Medicine. 2023 24(10). p.1029
Brief Report: Use and Side Effects of Sodium–Glucose Transporter 2 Inhibitors Among US People With HIV With Clinical Indications
Sise Meghan E.,
Katz-Agranov Nurit,
Strohbehn Ian A.,
Harden Destiny,
Moreno Daiana,
Durbin Claudia,
Toribio Mabel,
Neilan Tomas G., Zanni Markella V.
JAIDS Journal of Acquired Immune Deficiency Syndromes. 2023 94(1). p.53
